Clovis Oncology, Inc.
CLVSDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001466301
Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Clovis Oncology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Clovis Oncology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ivers-Read Gillian C | See Remarks | 293,612 | Nov 3, 2022 | 0 |
| Muehl Daniel W | See Remarks | 104,830 | Nov 3, 2022 | 0 |
| Rolfe Lindsey | See Remarks | 113,691 | Nov 3, 2022 | 0 |
| Gross Paul Edward | See Remarks | 98,330 | Nov 3, 2022 | 0 |
| Harding Thomas C. | See Remarks | 3,801Indirect | Nov 3, 2022 | 0 |
| Mahaffy Patrick J | See Remarks | – | Mar 3, 2022 | 0 |
| Simantov Ronit | Director | – | Jul 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Harding Thomas C.See Remarks | SSale | −1.50K | $0.64 | −$962.56 | −9.3%14.7K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Harding Thomas C.See Remarks | SSale | −218 | $0.64 | −$139.52 | −6.3%3.23K after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Harding Thomas C.See Remarks | SSale | −7 | $2.71 | −$18.97 | −0.2%3.23K after | |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Harding Thomas C.See Remarks | SSale | −1.73K | $1.46 | −$2.53K | −9.6%16.4K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Harding Thomas C.See Remarks | SSale | −77 | $1.46 | −$112.42 | −2.3%3.34K after | |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Gross Paul EdwardSee Remarks | SSale | −4.81K | $1.46 | −$7.02K | −5.1%90.1K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Ivers-Read Gillian CSee Remarks | SSale | −3.80K | $1.46 | −$5.55K | −1.3%286.1K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Rolfe LindseySee Remarks | SSale | −4.33K | $1.46 | −$6.32K | −3.9%107.1K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Muehl Daniel WSee Remarks | SSale | −4.65K | $1.46 | −$6.79K | −4.6%96.3K after | 2 lots |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Muehl Daniel WSee Remarks | SSale | −2.23K | $1.20 | −$2.68K | −2.2%99.2K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Ivers-Read Gillian CSee Remarks | SSale | −2.23K | $1.20 | −$2.68K | −0.8%288.9K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Harding Thomas C.See Remarks | SSale | −1.44K | $1.20 | −$1.73K | −7.5%17.8K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Harding Thomas C.See Remarks | SSale | −172 | $1.20 | −$206.4 | −4.5%3.67K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Gross Paul EdwardSee Remarks | SSale | −2.31K | $1.20 | −$2.77K | −2.4%92.8K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Rolfe LindseySee Remarks | SSale | −2.54K | $1.20 | −$3.05K | −2.3%109.6K after | |
| Oct 4, 2022 (view filing) | Oct 3 | 1 day | Harding Thomas C.See Remarks | SSale | −6 | $1.29 | −$7.74 | −0.2%3.68K after | |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Rolfe LindseySee Remarks | SSale | −4.26K | $0.98 | −$4.18K | −3.6%113.7K after | 2 lots |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Muehl Daniel WSee Remarks | SSale | −4.58K | $0.98 | −$4.49K | −4.2%104.8K after | 2 lots |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Harding Thomas C.See Remarks | SSale | −1.70K | $0.98 | −$1.67K | −8.0%19.5K after | 2 lots |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Harding Thomas C.See Remarks | SSale | −63 | $0.98 | −$61.74 | −1.6%3.80K after | |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Ivers-Read Gillian CSee Remarks | SSale | −3.68K | $0.98 | −$3.61K | −1.2%293.6K after | 2 lots |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Gross Paul EdwardSee Remarks | SSale | −4.73K | $0.98 | −$4.64K | −4.6%98.3K after | 2 lots |